RE: Greetings folks16 Jan 2017 16:07
Many thanks hoping.
It seems there is some very significant news in both Q1 & Q2 to land here. Note the latest from the broker,
Our view: This represents a crucial development towards the launch of Concepta’s flagship myLotus fertility product into the UK and European markets, where the potential market opportunity is circa £350 million. Further to this the CEO has confirmed that with regulatory approvals and manufacturing agreements already in place in China, the Group remains on track to roll out its myLotus product into the Chinese market in H1’2017 where, separately it has additional market potential put at around £250 million. Indeed, the total global opportunity addressed by Concepta’s current product offering is estimated to be worth as much as US$2 billion. Further out, its technology platform is expected to be developed into a much wider opportunity for personalised monitoring and self-diagnosis. Beaufort reiterates its Speculative Buy rating on the shares, with a price target of 26p.